The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116104385 11610438 5 F 20150825 20160706 20151008 20160719 EXP GB-AUROBINDO-AUR-APL-2015-08932 AUROBINDO 0.00 Y 0.00000 20160719 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116104385 11610438 1 SS Furosemide 40 mg FUROSEMIDE 1 Oral 40 MG, ONCE A DAY Y U UNK 0 40 MG QD
116104385 11610438 2 SS Furosemide 40 mg FUROSEMIDE 1 Oral 20 MG, UNK Y U 0 20 MG
116104385 11610438 3 PS Omeprazole 40mg OMEPRAZOLE 1 Oral 40 MG, ONCE A DAY Y U UNK 203270 40 MG QD
116104385 11610438 4 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 1400 MG, ONCE A DAY 7000 MG U U UNK 0 1400 MG QD
116104385 11610438 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 7000 MG U U 0
116104385 11610438 6 SS INOTUZUMAB OZOGAMICIN INOTUZUMAB OZOGAMICIN 1 Intravenous (not otherwise specified) 0.8 MG/M2, ONCE A DAY 6 MG U UNK 0 .8 MG/M**2 QD
116104385 11610438 7 SS INOTUZUMAB OZOGAMICIN INOTUZUMAB OZOGAMICIN 1 Intravenous (not otherwise specified) 6 MG U UNK 0 1.5 MG QD
116104385 11610438 8 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) DAY 1 1875 MG/M2 U U 0 375 MG/M**2 QD
116104385 11610438 9 SS PREDNISOLONE. PREDNISOLONE 1 Oral 100 MG, ONCE A DAY 500 MG U U UNK 0 100 MG QD
116104385 11610438 10 SS PREDNISOLONE. PREDNISOLONE 1 500 MG U U 0
116104385 11610438 11 SS RITUXIMAB RITUXIMAB 1 Intravenous (not otherwise specified) 720 MG, ONCE A DAY 3600 MG U U UNK 0 720 MG QD
116104385 11610438 12 SS RITUXIMAB RITUXIMAB 1 3600 MG U U 0
116104385 11610438 13 SS VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) 1.4 MG/M2, ONCE A DAY 10 MG U U UNK 0 2 MG QD
116104385 11610438 14 C ALLOPURINOL. ALLOPURINOL 1 Oral 300 MG, ONCE A DAY 3000 MG U 0 300 MG QD
116104385 11610438 15 C COATED ASPIRIN ASPIRIN 1 Oral 75 MG, ONCE A DAY U 0 75 MG QD
116104385 11610438 16 C CHLORPHENAMINE CHLORPHENIRAMINE MALEATE 1 Intravenous (not otherwise specified) 10 MG, ONCE A DAY 50 MG U 0 10 MG QD
116104385 11610438 17 C DIGOXIN. DIGOXIN 1 Oral 125 ?G, ONCE A DAY U 0 125 UG QD
116104385 11610438 18 C DIGOXIN. DIGOXIN 1 Unknown UNK U 0
116104385 11610438 19 C FILGRASTIM FILGRASTIM 1 Subcutaneous 300 ?G, ONCE A DAY 600 UG U 0 300 UG QD
116104385 11610438 20 C FLUCONAZOLE. FLUCONAZOLE 1 Oral 50 MG, ONCE A DAY 500 MG U 0 50 MG QD
116104385 11610438 21 C HYDROXYCHLOROQUINE HYDROXYCHLOROQUINE 1 Oral 200 MG, TWO TIMES A DAY 4400 MG U 0 200 MG BID
116104385 11610438 22 C LEFLUNOMIDE. LEFLUNOMIDE 1 Oral 20 MG, ONCE A DAY U 0 20 MG QD
116104385 11610438 23 C METOCLOPRAMIDE. METOCLOPRAMIDE 1 Oral DOSE: 10-20 MG U 0
116104385 11610438 24 C ONDANSETRON ONDANSETRON 1 Oral 8 MG, ONCE A DAY 40 MG U 0 8 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116104385 11610438 1 Cardiac disorder
116104385 11610438 3 Gastrointestinal haemorrhage
116104385 11610438 4 Neoplasm malignant
116104385 11610438 5 Diffuse large B-cell lymphoma
116104385 11610438 6 Diffuse large B-cell lymphoma
116104385 11610438 8 Diffuse large B-cell lymphoma
116104385 11610438 9 Diffuse large B-cell lymphoma
116104385 11610438 10 Neoplasm malignant
116104385 11610438 11 Diffuse large B-cell lymphoma
116104385 11610438 12 Neoplasm malignant
116104385 11610438 13 Diffuse large B-cell lymphoma
116104385 11610438 14 Prophylaxis
116104385 11610438 15 Aortic valve replacement
116104385 11610438 16 Unevaluable event
116104385 11610438 17 Atrial fibrillation
116104385 11610438 19 White blood cell count
116104385 11610438 20 Antifungal prophylaxis
116104385 11610438 21 Rheumatoid arthritis
116104385 11610438 22 Rheumatoid arthritis
116104385 11610438 23 Vomiting
116104385 11610438 24 Vomiting

Outcome of event

Event ID CASEID OUTC COD
116104385 11610438 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116104385 11610438 Blood lactic acid increased
116104385 11610438 Hyponatraemia
116104385 11610438 Lower respiratory tract infection
116104385 11610438 Productive cough

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116104385 11610438 1 20150826 0
116104385 11610438 3 20150826 0
116104385 11610438 4 20150820 20150820 0
116104385 11610438 6 20150821 0
116104385 11610438 7 20150821 20150821 0
116104385 11610438 8 20150820 20150820 0
116104385 11610438 9 20150820 20150824 0
116104385 11610438 11 20150820 20150820 0
116104385 11610438 13 20150820 20150820 0
116104385 11610438 14 20150815 20150826 0
116104385 11610438 15 20150826 0
116104385 11610438 16 20150820 20150820 0
116104385 11610438 17 20150826 0
116104385 11610438 18 20150815 20150826 0
116104385 11610438 19 20150823 20150826 0
116104385 11610438 20 20150815 20150826 0
116104385 11610438 21 20150814 20150826 0
116104385 11610438 22 201107 20150826 0
116104385 11610438 23 20150820 20150826 0
116104385 11610438 24 20150820 20150820 0